Cocrystal Pharma, Inc. (COCP)
NASDAQ: COCP · Real-Time Price · USD
1.380
-0.010 (-0.72%)
Apr 29, 2026, 11:18 AM EDT - Market open
Cocrystal Pharma Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -8.83 | -17.5 | -17.98 | -38.84 | -14.19 | |
| Depreciation & Amortization | 0.07 | 0.13 | 0.19 | 0.19 | 0.38 | |
| Asset Writedown & Restructuring Costs | - | - | - | 19.09 | - | |
| Stock-Based Compensation | 0.27 | 0.64 | 0.8 | 0.86 | 0.72 | |
| Other Operating Activities | 0 | 0.11 | -0.01 | -0.02 | -0.24 | |
| Change in Accounts Receivable | - | - | - | - | 0.56 | |
| Change in Accounts Payable | -0.25 | -0.9 | 2.05 | -0.32 | 0.22 | |
| Change in Other Net Operating Assets | 0.04 | 1.36 | 0.47 | -1.68 | -0.17 | |
| Operating Cash Flow | -8.19 | -16.49 | -14.67 | -21.44 | -12.72 | |
| Capital Expenditures | -0.01 | -0.01 | -0.12 | -0.07 | -0.05 | |
| Investing Cash Flow | -0.01 | -0.01 | -0.12 | -0.07 | -0.05 | |
| Long-Term Debt Repaid | - | - | -0.01 | -0.03 | -0.04 | |
| Net Debt Issued (Repaid) | - | - | -0.01 | -0.03 | -0.04 | |
| Issuance of Common Stock | 5.37 | - | 4 | - | 38.51 | |
| Financing Cash Flow | 5.37 | - | 3.99 | -0.03 | 38.47 | |
| Net Cash Flow | -2.84 | -16.49 | -10.79 | -21.54 | 25.7 | |
| Free Cash Flow | -8.2 | -16.49 | -14.78 | -21.51 | -12.77 | |
| Free Cash Flow Per Share | -0.73 | -1.62 | -1.53 | -2.64 | -1.73 | |
| Levered Free Cash Flow | -4.95 | -10.29 | -10.01 | -13.12 | -7.28 | |
| Unlevered Free Cash Flow | -4.95 | -10.29 | -10.01 | -13.12 | -7.28 | |
| Change in Working Capital | 0.29 | 0.14 | 2.34 | -2.71 | 0.6 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.